Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Mizuho Maintains Buy on MiMedx Group, Raises Price Target to $14

Author: Benzinga Newsdesk | March 01, 2024 10:48am
Mizuho analyst Anthony Petrone maintains MiMedx Group (NASDAQ:MDXG) with a Buy and raises the price target from $13 to $14.

Posted In: MDXG

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist